KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Pediatrics / 2021 / Cilt: 63 - Sayı: 6

Covid-19 in a patient with Familial Hemophagocytic Lymphohistiocytosis in children

V. Hülya ÜZEL
Kamil YILMAZ
Sayfa
1103–1107
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

It should be remembered that COVID-19 can be seen with different clinical manifestations in the pediatric age group, and COVID-19 tests should be recommended, especially in children with immunosuppression and fever

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Based on the information obtained so far, COVID- 19 is relatively mild in children.
📊
Temel Bulgular & Veri:We will present a 6-month-old male patient infected with COVID -19 in April 2020, while receiving HLH 2004 chemotherapy protocol with the diagnosis of familial (Genetic / Primary) Hemophagocytic Lymphohistiocytosis (HLH).
💡
Sonuç & Katkı:It should be remembered that COVID-19 can be seen with different clinical manifestations in the pediatric age group, and COVID-19 tests should be recommended, especially in children with immunosuppression and fever
🔬Tür:Araştırma Makalesi
📍Kapsam:2020 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Background. Based on the information obtained so far, COVID- 19 is relatively mild in children. We will present a 6-month-old male patient infected with COVID -19 in April 2020, while receiving HLH 2004 chemotherapy protocol with the diagnosis of familial (Genetic / Primary) Hemophagocytic Lymphohistiocytosis (HLH). Case. Herein we present a case accompanied by a defective perforin gene defect in the primary HLH pathogenesis, Covid-19 infection with the presence of fever and hyperferritinemia, which was evaluated in favor of reactivation and the patient was given both the HLH-2004 chemotherapy protocol treatment and COVID -19 therapy as recommended by the guidelines. Our patient improved clinically and in terms of laboratory test results at the end of the 15th day of hospitalization and was discharged. Conclusions. It should be remembered that COVID-19 can be seen with different clinical manifestations in the pediatric age group, and COVID-19 tests should be recommended, especially in children with immunosuppression and fever

🔖

Bu Makaleye Atıf Yap

ÜZEL, V. H., YILMAZ, K. (2021). Covid-19 in a patient with Familial Hemophagocytic Lymphohistiocytosis in children. Turkish Journal of Pediatrics, Cilt: 63 - Sayı: 6, 1103–1107. https://ajindex.com/articles/411788

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (4)

  1. World Health Organization. Coronavirus disease (COVID-19) pandemic. Available at: https:// w w w. w h o. i n t / e m e r g e n c i e s / d i s e a s e s / n o ve l - coronavirus-2019 (Accessed on May 2, 2020)
  2. Tezer H, Bedir Demirdağ T. Novel coronavirus disease (COVID-19) in children. Turk J Med Sci 2020; 50(SI-1): 592-603. https://doi.org/10.3906/sag- 2004-174 3. Sullivan M, Bouffet E, Rodriguez-Galindo C, et al. The COVID-19 pandemic: a rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global. Pediatr Blood Cancer 2020; 67: e28409. https://doi. org/10.1002/pbc.28409 4. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med 2012; 63: 233-246. https://doi.org/10.1146/annurev- med-041610-134208 5. Zhu N, Zhang D, Wang W, et al; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382: 727-733. https:// doi.org/10.1056/NEJMoa2001017 6. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 2020; 15: 700-704.
  3. Ueda I, Morimoto A, Inaba T, et al. Characteristic perforin gene mutations of haemophagocytic lymphohistiocytosis patients in Japan. Br J Haematol 2003; 121: 503-510. https://doi.org/10.1046/j.1365- 2141.2003.0429.x 8. Filipovich AH, Chandrakasan S. Pathogenesis of hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 2015; 29: 895-902. https://doi. org/10.1016/j.hoc.2015.06.007 9. Bode SF, Ammann S, Al-Herz W, et al; Inborn Errors Working Party of the EBMT. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. Haematologica 2015; 100: 978-988. https://doi.org/10.3324/ haematol.2014.121608 10. Fox SE, Akmatbekov A, Harbert JL, et al. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med 2020; 8: 681-686. https:// doi.org/10.1016/S2213-2600(20)30243-5 11. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 2020; 15: 700-704.
  4. McGonagle D, Sharif K, O’Regan A, Bridgewood C. The role of